GlassScriptPhysician profile
Garrett H Garner
NPI 1679575393
$14,975.79
in general payments reported to CMS, 2019-2025
53 companies · $8,922 in 2025
The $8,922 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $110 · 2021: $755 · 2022: $950 · 2023: $685 · 2024: $3,099 · 2025: $8,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $1,879 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,800.00 |
| Food and Beverage | $1,878.77 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $10,800.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $540.37 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $463.00 | 2021-2025 | |
| Astellas Pharma US INC | $329.75 | 2023-2025 | Veozah |
| Millicent US INC | $220.75 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Sage Therapeutics, LLC | $214.63 | 2019-2025 | Zurzuvae |
| Exeltis, USA INC. | $197.26 | 2020-2025 | Slynd |
| Organon LLC | $182.79 | 2021-2025 | Nexplanon |
| Pfizer INC. | $162.00 | 2019-2024 | |
| Hologic Sales and Service, LLC | $136.24 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay, Myosure Tissue Removal Device, Novasure |
| Aspira Women'S Health INC | $117.51 | 2022-2023 | Ova1 |
| Pacira Pharmaceuticals Incorporated | $91.47 | 2019-2023 | Exparel, Iovera, Zilretta |
| Avion Pharmaceuticals | $86.15 | 2019-2023 | Balcoltra |
| Meditrina | $76.22 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $75.86 | 2023-2025 | Myfembree |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.